0001415889-23-016089.txt : 20231208 0001415889-23-016089.hdr.sgml : 20231208 20231208171136 ACCESSION NUMBER: 0001415889-23-016089 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231208 FILED AS OF DATE: 20231208 DATE AS OF CHANGE: 20231208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Straube Richard CENTRAL INDEX KEY: 0001595197 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14778 FILM NUMBER: 231476295 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE, SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 4 1 form4-12082023_101231.xml X0508 4 2023-12-08 0000812796 SOLIGENIX, INC. SNGX 0001595197 Straube Richard C/O SOLIGENIX, INC. 29 EMMONS DRIVE, SUITE B-10 PRINCETON NJ 08540 false true false false SENIOR VICE PRESIDENT AND CMO 0 Option (Right to Buy) 0.67 2023-12-08 4 A 0 75000 0 A 2023-12-08 2033-12-07 Common Stock 75000 75000 D The stock option vested immediately as to 25% of the shares and vests as to the remaining 75% of the shares in 12 equal installments (or nearly equal installments if the number of remaining shares is not evenly divisible by 12) on each three (3) month anniversary of December 8, 2023. /s/ Richard Straube 2023-12-08